SCHEMBL7192241

SCHEMBL7192241

O=C(O)C(=O)CC(=O)c1ccc(Cc2cccc(Cl)c2)[nH]1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FEN1 P39748 6/20 0.52
ERCC5 P28715 5/20 0.52
HCAR2 Q8TDS4 1/20 0.48
DAO P14920 1/20 0.43
CTBP2 P56545 1/20 0.42
HAO1 Q9UJM8 1/20 0.41
KDM4A O75164 1/20 0.41
KDM4C Q9H3R0 1/20 0.41
KDM5B Q9UGL1 1/20 0.41
PTPN1 P18031 1/20 0.41
PDE5A O76074 2/20 0.40
BRS3 P32247 1/20 0.39
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP9 P14780 1/20 0.39
MMP12 P39900 1/20 0.39
PLAAT3 P53816 1/20 0.39
PLAAT5 Q96KN8 1/20 0.39
PLAAT2 Q9NWW9 1/20 0.39
PLAAT4 Q9UL19 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7192873 0.85 FEN1 (0.47) FEN1ERCC5HCAR2HAO1PTPN1
SCHEMBL7193837 0.85 HCAR2 (0.48) FEN1ERCC5HCAR2DAOKDM4C
SCHEMBL6951230 0.77 FEN1 (0.77) FEN1ERCC5CTBP2HAO1PTPN1
SCHEMBL7188309 0.76 HAO1 (0.39) FEN1ERCC5DAOCTBP2HAO1
SCHEMBL7665718 0.76 HAO1 (0.70) FEN1ERCC5CTBP2HAO1PTPN1
Dimethylamine SCHEMBL6951644 0.75 FEN1 (0.73) FEN1ERCC5CTBP2HAO1PTPN1
SCHEMBL4380912 0.72 HCAR2 (0.54) HCAR2DAOCTBP2KDM4AKDM4C
SCHEMBL7826555 0.72 FEN1 (0.52) FEN1ERCC5CTBP2HAO1PTPN1
SCHEMBL7818274 0.71 FEN1 (0.58) FEN1ERCC5DAOCTBP2HAO1
SCHEMBL7828681 0.71 FEN1 (0.51) FEN1ERCC5HCAR2CTBP2HAO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1083897-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-01-02 EP claimed
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US claimed
EP-1083897-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-21 EP claimed
WO-1999062513-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO claimed
EP-1083897-A4 HIV INTEGRASE INHIBITORS MERCK & CO INC (US) 2003-01-02 EP disclosed
US-6306891-B1 INHIBITORS OF HIV INTEGRASE AND INHIBITORS OF HIV REPLICATION. THESE COMPOUNDS ARE USEFUL IN THE PREVENTION OR TREATMENT OF INFECTION BY HIV TREATMENT OF AIDS, EITHER AS COMPOUNDS, PHARMACEUTICALLY ACCEPTABLE SALTS MERCK & CO., INC. 2001-10-23 US disclosed
EP-1083897-A1 HIV INTEGRASE INHIBITORS Merck & Co., Inc. (US) 2001-03-21 EP disclosed
WO-1999062513-A1 HIV INTEGRASE INHIBITORS MERCK & CO., INC. (US) 1999-12-09 WO disclosed